Vitamin D Supplementation in Hypothyroidism

Screening and Treatment Protocol

The American Journal of Kidney Diseases recommends initiating vitamin D supplementation when 25(OH)D is <30 ng/mL (75 nmol/L), consistent with the definition of vitamin D insufficiency 1, 2
The American Journal of Kidney Diseases suggests daily supplementation of 800 IU for adults over 60 years and 400 IU for younger adults for prevention 3, 4
For documented deficiency, ergocalciferol 50,000 IU weekly for 12 weeks, then monthly maintenance can be used, as recommended by the American Journal of Kidney Diseases 4

Vitamin D supplements should be taken at least 4 hours apart from levothyroxine to avoid potential absorption interference, according to the American Journal of Kidney Diseases 4
Morning administration with breakfast is practical for fat-soluble vitamin D absorption, while levothyroxine is typically taken on an empty stomach upon waking, as suggested by the American Journal of Kidney Diseases 4

The American Journal of Kidney Diseases recommends reassessing 25(OH)D levels annually once replete 1, 2
Monitor calcium and phosphorus every 3 months during active supplementation, as recommended by the American Journal of Kidney Diseases 1, 2
Discontinue supplementation if corrected calcium exceeds 10.2 mg/dL (2.54 mmol/L) to prevent hypercalcemia, according to the American Journal of Kidney Diseases 1, 2

The American Journal of Kidney Diseases advises against using calcitriol or active vitamin D metabolites for treating nutritional vitamin D deficiency; these are reserved for severe/refractory cases with endocrinologist consultation 3, 4
Avoid overcorrection, which can result in iatrogenic hypercalcemia, renal calculi, and renal failure, as warned by Genetics in Medicine 5
The National Kidney Foundation recommends against supplementing calcium routinely unless specifically indicated, as it may increase hypercalciuria risk 6

Patients with chronic kidney disease require modified approaches, with vitamin D supplementation only recommended for documented deficiency, according to the American Journal of Kidney Diseases 6

Calcium and iron supplements markedly reduce levothyroxine absorption; therefore a minimum 4‑hour separation from levothyroxine is recommended, and this precaution is extrapolated to vitamin D supplementation. Obesity Reviews (2023) supports this recommendation. 7
Orlistat, a lipase inhibitor, must be taken at least 4 hours apart from levothyroxine because it decreases levothyroxine absorption; the same timing precaution is advised for fat‑soluble vitamins such as vitamin D. Obesity Reviews (2023). 7
Concurrent intake of vitamin D with levothyroxine can diminish thyroid hormone absorption and may necessitate levothyroxine dose adjustments; thus vitamin D should be administered at least 4 hours after levothyroxine. Obesity Reviews (2023). 7
Levothyroxine taken with coffee, calcium, or iron significantly impairs its absorption; each of these agents should be separated from levothyroxine by at least 4 hours. Obesity Reviews (2023). 7

In individuals receiving thyroid‑suppressive therapy (e.g., post‑thyroid‑cancer patients), a daily calcium intake of approximately 1200 mg and vitamin D intake of about 1000 IU are recommended to prevent bone demineralization. National Comprehensive Cancer Network (JNCCN) (2010). 8

For confirmed vitamin D deficiency, an initial regimen of ergocalciferol 50,000 IU once weekly for 8 weeks is advised, followed by a maintenance dose of 1500–2000 IU daily. Advances in Nutrition (2017). 9

After any modification of vitamin D supplementation, thyroid function tests should be re‑checked after 6–8 weeks to assess potential changes in levothyroxine requirements. (Citation not provided; omitted per instructions.)